Bide Pharmatech Hits Day Low of CNY 48.00 Amid Price Pressure

Bide Pharmatech Co., Ltd. experienced a significant decline today, with the stock dropping by 15.11% and reaching an intraday low of CNY 48.00. This performance stands in contrast to the broader market, as the China Shanghai Composite index fell by only 3.05% on the same day. Over the past week, Bide Pharmatech has seen an 8.29% decrease, while its one-year performance reflects a decline of 19.52%. Year-to-date, the stock has lost 20.31%, significantly underperforming the China Shanghai Composite, which is down 5.16% during the same period. Despite these challenges, the company reported positive financial metrics, including a notable increase in net sales, which reached CNY 351.58 million. Additionally, the raw material costs have decreased by 6.78% year-over-year, contributing to a favorable debtors turnover ratio of 4.88 times. With a return on equity of 6.97% and a price-to-book ratio of 3.56, Bide Pharmatech maintains a competitive valuation within the pharmaceuticals and biotechnology sector.